Correction: Fararjeh, A-F S., et al. ZBTB46, SPDEF, ETV6 Novel Potential Biomarkers and Therapeutic Targets in Castration Resistance Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 2802

Abdul-Fattah Salah Fararjeh; Yen-Nien Liu

doi:10.3390/ijms21124243

and

¹

Department of Medical Laboratory Sciences, Faculty of Science, Al-Balqa Applied University, Al-Salt 19117, Jordan

²

Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan

³

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan

^*

Author to whom correspondence should be addressed.

Int. J. Mol. Sci.2020, 21(12), 4243;https://doi.org/10.3390/ijms21124243

This article belongs to the Special Issue Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer 2019

Version Notes

Order Reprints

The authors wish to make the following correction to this paper [1]: PSA, which was described as being initiated in “1979”, was actually initiated in “1970”.

The authors would like to apologize for any inconvenience caused to the readers by this change.

Reference

Fararjeh, A.-F.S.; Liu, Y.N. ZBTB46, SPDEF, ETV6 novel potential biomarkers and therapeutic targets in castration resistance prostate cancer. Int. J. Mol. Sci. 2019, 20, 2802. [Google Scholar] [CrossRef] [PubMed]

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Correction: Fararjeh, A-F S., et al. ZBTB46, SPDEF, ETV6 Novel Potential Biomarkers and Therapeutic Targets in Castration Resistance Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 2802

Reference

Article Metrics

Citations

Article Access Statistics